Tradestie Institutional Equity Comparison Engine

SYRE vs TECH โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

TECH Overall Edge

TECH Captures Institutional Edge (4โ€“0 Pillars ยท 10โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Bio-Techne Corp. (TECH) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, SYRE trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus TECH at 42.8x Forward P/E and 21.7% operating margin (+4.6% YoY). In options structure, SYRE sits in UNCLASSIFIED (10th %ile IV; Dealer Gamma Walls on Pro) against TECH sits in UNCLASSIFIED (6th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner TECH
SYRE N/M vs TECH 42.8x Fwd P/E
Growth & Margin Winner TECH
Op Margin 0.0% vs 21.7% ยท YoY +0.0% vs +4.6%
Momentum & Technical Winner TECH
1Y +341.7% vs +19.8% ยท 52W Pos 88% vs 100%
Options & Structure Winner TECH
UNCLASSIFIED (10th %ile IV) vs UNCLASSIFIED (6th %ile IV)
SYRE NASDAQ
Spyre Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$99.97
-3.88% 1D
Market Cap $9.8B
1M Return +25.11%
1Y Return +341.74%
Forward P/E N/M
Unified AI Score
36.1 / 100 SELL
Tech 8.0 Fund 33.0 Flow 50.0 Mom 50.0
TECH NASDAQ
Bio-Techne Corp.
Biological Products, (No Disgnostic Substances)
$72.79
-0.01% 1D
Market Cap $11.4B
1M Return +0.3%
1Y Return +19.82%
Forward P/E 42.8x
Unified AI Score
52.4 / 100 HOLD
Tech 40.0 Fund 46.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SYRE +341.74% TECH +19.82% Spread: +321.92 pp (SYRE Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
SYRE TTM Op. Margin: 0.0% TECH TTM Op. Margin: 21.7%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SYRE vs TECH. Trailing 12-month operating profitability (SYRE 0.0% vs TECH 21.7%) and valuation multiples (SYRE N/M vs TECH 42.8x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SYRE (0) vs TECH (10)
Institutional Metric SYRE TECH Criterion Row Winner
Market Capitalization Scale $9.8B $11.4B Larger Scale TECH
Trailing P/E Ratio Valuation N/M 66.8x Lower Multiple TECH
Forward P/E Ratio Valuation N/M 42.8x Lower Multiple TECH
Revenue Growth (YoY) Growth +0.0% +4.6% Higher Growth TECH
Operating Margin (TTM) Profitability 0.0% 21.7% Higher Margin TECH
Net Profit Margin Profitability 0.0% 14.0% Higher Margin TECH
Return on Equity (ROE) Capital Efficiency -35.0% 8.3% Higher ROE TECH
52-Week Range Position Momentum 88% ($22โ€“$111) 100% ($43โ€“$73) Stronger Trend TECH
Beta / 30D Volatility Risk Regime 1.75ฮฒ ยท 59% Vol 0.37ฮฒ ยท 1% Vol Lower Realized Risk TECH
Unified Institutional Score Composite Signal 36.1 / 100 (SELL) 52.4 / 100 (HOLD) Higher Composite TECH

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SYRE vs TECH Buy Guide
SYRE UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 10th %ile
IV Regime Compressed (<25th %ile)
Live SYRE Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
TECH UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live TECH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SYRE nor TECH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.